Stay updated on MSB0011359C in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MSB0011359C in Solid Tumors Clinical Trial page.

Latest updates to the MSB0011359C in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a Phase I study for the drug MSB0011359C (M7824) and the addition of collaborators and a revision number. The core content regarding the study's purpose and methodology has been largely deleted.SummaryDifference17%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.7%
Stay in the know with updates to MSB0011359C in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MSB0011359C in Solid Tumors Clinical Trial page.